Chemistry:UK-414,495
From HandWiki
Short description: Female sexual arousal disorder medication
 | |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C16H25N3O3S |
| Molar mass | 339.45 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
UK-414,495 is a drug developed by Pfizer for the treatment of female sexual arousal disorder. UK-414,495 acts as a potent, selective inhibitor of the enzyme neutral endopeptidase, which normally serves to break down the neuropeptide VIP. The consequent increase in VIP activity alters blood flow to the genital region leading to increased lubrication and muscle relaxation.[1][2][3]
See also
- ABT-670
- ABT-724
- Bremelanotide
- Cabergoline
- Flibanserin
- Testosterone (patch)
- Melanotan II
- Pramipexole
- PF-219,061
- S-17092
- Tibolone
References
- ↑ "Recent disclosures of clinical drug candidates". Drug News & Perspectives 19 (1): 65–72. 2006. PMID 16550257.
- ↑ "Neutral endopeptidase inhibition: could it have a role in the treatment of female sexual arousal disorder?". British Journal of Pharmacology 160 (1): 48–50. May 2010. doi:10.1111/j.1476-5381.2010.00693.x. PMID 20412067.
- ↑ "UK-414,495, a selective inhibitor of neutral endopeptidase, potentiates pelvic nerve-stimulated increases in female genital blood flow in the anaesthetized rabbit". British Journal of Pharmacology 160 (1): 51–59. May 2010. doi:10.1111/j.1476-5381.2010.00691.x. PMID 20412068.
 |  |
